Feature | VIVA | November 14, 2019

VIVA 2019 Late-breaking Clinical Trials

The latest clinical data in vascular medicine and peripheral vascular interventions

Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular Interventional Advances (VIVA) 2019 conference. These results were presented in four different sessions on Nov. 5-6, 2019, in VIVA's Global Theater. VIVA highlights the latest science in vascular and peripheral vascular interventions.
 

Tuesday Late-breakers, November 5:

   • No Increased Mortality for the Zilver PTX Drug-Eluting Stent Compared to Uncoated Devices, presented by Michael Dake, M.D.

   • A Novel Sustained Sirolimus Release Eluting Balloon: 2-Year Data From the SELUTION SFA Trial, presented by Thomas Zeller, M.D., Ph.D.

   • RANGER II SFA: Randomized Trial of RANGER DCB vs. PTA in the SFA, presented by Ravish Sachar, M.D.

   • 4-Year Outcomes From the IN.PACT Global Study, presented by Thomas Zeller, M.D., Ph.D.

   • DCB vs POBA After B-laser Atherectomy Shows No Difference, presented by John Rundback, M.D.

   • Two-Year Outcomes From the IMPERIAL Randomized Trial of Eluvia and Zilver PTX, presented by Osamu Iida, M.D.

 

   • Full Cohort 24-Month Safety and Efficacy Results of the VMI-CFA Common Femoral Stenting Trial, presented by Koen Deloose, M.D.

   • Nexus Aortic Arch Branch Stent-Graft System – Mid-Term Results, presented by Mario Lachat, M.D.

   • Revolution Rotational Atherectomy System IDE Experience, presented by Jeffrey Carr, M.D.

   • 1-year Results From the MIMICS-3D Registry: Investigating the BioMimics 3D Stent, presented by Michael Lichtenberg, M.D.

   • Treatment of BTK Disease With a Novel Device: Update on the DEEPER OUS Trial, presented by Thomas Zeller, M.D., Ph.D.

 

Wednesday Late-breakers, November 6:

   • 6-Months Results of TOBA II BTK, presented by George Adams, M.D.

   • 5-Year ABSORB BTK Trial Results, presented by Ramon Varcoe, MBBS, MS, Ph.D.

   • Results of the PROMISE I Trial Using the LimbFlow Bypass System in Limb-threatening Ischemia, presented by Daniel Clair, M.D.

   • Initial 12-Month Outcomes From the TANGO Trial (Adventitial Temsirolimus in BTK Lesions), presented by Ehrin Armstrong, M.D.

   • The Ulysse Registry Shows Benefit of Ultrasoundplasty in Below-the-knee Interventions, presented by Costantino Del Giudice, M.D., Ph.D.

    
   • IN.PACT AV Access 6-month Lesion Outcomes, presented by Robert Lookstein, M.D., MHCDL

   • Lateral Subdermic Plexus Insufficiency: A Paradigm Shift With Restless Leg Syndrome, presented by Swar Shah, M.D.

   • Early Outcomes From the ClotTriever (CLOUT) Registry in DVT, presented by David Dexter, M.D.

   • Indigo Aspiration System for Acute Pulmonary Embolism, presented by Akhilesh Sista, M.D.

   • 1-Year Results of the DISAPEAR Registry, presented by Steven Kum, M.D.

 

 
Related Late-breaking Cardiovascular Trials:

ACC 2019 Late-breaking Presentations

Late-breaking Interventional Cardiology Presentations at SCAI 2019

American Heart Association 2018 Late-breaking Trials

TCT 2019 Late-breaking Presentations

American Heart Association 2019 Late-breaking Trials

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...